Atlas Trials

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg

Clinical trial NCT03329261 · COMPLETED

Trial details

NCT number
NCT03329261
Sponsor
Laboratoires Teriak
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2NSTEMI - Non-ST Segment Elevation MICoronary Angioplasty
Start date
2017-12-07
Primary completion
2019-03-24
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.